Rankings
▼
Calendar
IONS Q1 2021 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$12B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$112M
-16.3% YoY
Gross Profit
$109M
97.7% margin
Operating Income
-$92M
-82.4% margin
Net Income
-$90M
-80.5% margin
EPS (Diluted)
$-0.64
QoQ Revenue Growth
-61.6%
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$58M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$1.6B
Stockholders' Equity
$681M
Cash & Equivalents
$414M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$112M
$133M
-16.3%
Gross Profit
$109M
$131M
-16.7%
Operating Income
-$92M
-$61M
-50.5%
Net Income
-$90M
-$40M
-126.8%
Revenue Segments
Commercial
$84M
43%
Spinraza Royalties
$60M
31%
Research and Development Revenue Under Collaborative Agreements
$27M
14%
Product
$20M
10%
Licensing and Other Royalties
$5M
2%
← FY 2021
All Quarters
Q2 2021 →